The application of human phase 0 microdosing trials: A systematic review and perspectives-Reference-Cited by-同舟云学术

The application of human phase 0 microdosing trials: A systematic review and perspectives

Published:2015-11-16 Issue:6 Volume:57 Page:1281-1290
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Svendsen Pernille,El-Galaly Tarec C.,Dybkær Karen,Bøgsted Martin,Laursen Maria B.,Schmitz Alexander,Jensen Paw,Johnsen Hans E.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2015.1101097

Reference54 articles.

1. International Conference on Harmonisation. ICH guideline M3(R2) on non-clinical safety studies for the conduct of human clinical trials and marketing authorisation for pharmaceuticals. December 2009.

2. A Review of Human Phase 0 (Microdosing) Clinical Trials Following the US Food and Drug Administration Exploratory Investigational New Drug Studies Guidance

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Experimental models of endocrine responsive breast cancer: strengths, limitations, and use;Cancer Drug Resistance;2021

2. Pharmacokinetic characterization of drugs and new product development;Biopharmaceutics and Pharmacokinetics Considerations;2021

3. Midazolam microdosing applied in early clinical development for drug–drug interaction assessment;British Journal of Clinical Pharmacology;2020-06-10

4. References;Ethical Considerations When Preparing a Clinical Research Protocol;2020

5. Designing a clinical research study;Ethical Considerations When Preparing a Clinical Research Protocol;2020